This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Peter K. Honig, MD; Louis R. Cantilena, MD, PhD
Bethesda, Md

Arch Intern Med. 1994;154(9):1038-1041.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

We read with interest the article on ketoconazole and fluconazole drug interactions by Baciewicz and Baciewicz,¹ which appeared in the ARCHIVES. We agree that the azole antifungals have the capability to influence the metabolism of a wide variety of concurrently administered drugs and the Food and Drug Administration is increasingly aware of such potential interactions.²

The authors fail to cite recent information regarding interactions between the popular nonsedating antihistamines and these antifungal agents. A prospective study³ conducted by our group has shown ketoconazole to influence the biotransformation of terfenadine, allowing the accumulation of the cardiotoxic parent compound. The concomitant administration of these drugs is contraindicated. A similar interaction study of terfenadine and fluconazole did not demonstrate any clinically significant cardiac repolarization abnormalities.⁴

We also feel that it is important to mention that concomitant administration of ketoconazole and astemizole is contraindicated (as indicated on Hismanal [Janssen Pharmaceutica, . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?